A modality-aware CRISPR actionability framework for functional prioritization of genome-wide significant type 2 diabetes loci
Molecular Genetics and Genomics · 2026-12 · 301 (1)
DOI: 10.1007/s00438-026-02448-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Genetics and Genomics, online erschienen am 16.06.2026. Verfasst von Mehboob Uddin Mohd und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, A.V. College of Arts, Science and Commerce, Osmania University, Hyderabad, 500029, Telangana, India. mmehboobuddin@gmail…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Genome-Wide Association Study, CRISPR-Cas Systems, Gene Editing. Die Arbeit nennt 28 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Genome-wide association studies (GWAS) have identified numerous loci associated with Type 2 Diabetes (T2D), yet translating statistical signals into experimentally testable hypotheses remains a central challenge in post-GWAS biology. The predominance of non-coding regulatory variants complicates target gene assignment and raises uncertainty regarding optimal clustered regularly interspaced short palindromic repeats (CRISPR) perturbation strategy. Here, we present a structured CRISPR Actionability Framework that integrates genomic context, pancreatic islet enhancer overlap, tissue-specific expression validation, and locus clarity into a quantitative CRISPR Actionability Score (CAS). We applied this framework to ten genome-wide significant T2D loci and assigned modality-aware CRISPR strategies (knockout versus CRISPR interference). CAS values ranged from 4 to 10, enabling tiered prioritization into high, moderate, and lower experimental priority classes. High-priority loci included SLC30A8, TCF7L2, and KCNJ11, which demonstrated strong regulatory or coding evidence combined with islet expression support. By explicitly linking genomic architecture to perturbation modality, this framework provides a transparent and reproducible bridge between statistical genetics and functional genome editing. This approach establishes a scalable template for rational CRISPR target selection in complex disease research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Sciences, A.V. College of Arts, Science and Commerce, Osmania University, Hyderabad, 500029, Telangana, India. mmehboobuddin@gmail.com.
- Department of Life Sciences, A.V. College of Arts, Science and Commerce, Osmania University, Hyderabad, 500029, Telangana, India.
Zitieren
APA
Mohd, M. U., & Khan, S. M. Z. A. (2026). A modality-aware CRISPR actionability framework for functional prioritization of genome-wide significant type 2 diabetes loci. Molecular Genetics and Genomics, 301(1). https://doi.org/10.1007/s00438-026-02448-6
Vancouver
Mohd MU, Khan SMZA. A modality-aware CRISPR actionability framework for functional prioritization of genome-wide significant type 2 diabetes loci. Molecular Genetics and Genomics. 2026;301(1). doi:10.1007/s00438-026-02448-6
BibTeX
@article{Mohd2026,
author = {Mohd, Mehboob Uddin and Khan, Syed Mohd Zakariya Ali},
title = {A modality-aware CRISPR actionability framework for functional prioritization of genome-wide significant type 2 diabetes loci},
journal = {Molecular Genetics and Genomics},
year = {2026},
volume = {301},
number = {1},
doi = {10.1007/s00438-026-02448-6}
}
EUVIMED